References
- StuppRMasonWPvan den BentMJRadiotherapy plus concomitant and adjuvant temozolomide for glioblastomaN Engl J Med20053521098799615758009
- BoboRHLaskeDWAkbasakAMorrisonPFDedrickRLOldfieldEHConvection-enhanced delivery of macromolecules in the brainProc Natl Acad Sci U S A1994916207620808134351
- MorrisonPFLaskeDWBoboHOldfieldEHDedrickRLHigh-flow microinfusion: tissue penetration and pharmacodynamicsAm J Physiol19942661 pt 2R292R3058304553
- PanseSJFillmoreHLChenZJGilliesGTBroaddusWCA novel coaxial tube catheter for central nervous system infusions: performance characteristics in brain phantom gelJ Med Eng Technol2010357–8408414
- KunwarSChangSWestphalMPhase III randomized trial of CED of IL13-PE38QQR vs Gliadel wafers for recurrent glioblastomaNeuro Oncol201012887188120511192
- KunwarSPradosMDChangSMDirect intracerebral delivery of cintredekin besudotox (IL13-PE38QQR) in recurrent malignant glioma: a report by the Cintredekin Besudotox Intraparenchymal Study GroupJ Clin Oncol200725783784417327604
- SampsonJHAkabaniGArcherGEIntracerebral infusion of an EGFR-targeted toxin in recurrent malignant brain tumorsNeuro Oncol200810332032918403491
- GimenezFKrauzeMTVallesFImage-guided convection-enhanced delivery of GDNF protein into monkey putamenNeuroimage201154suppl 1S189S19520080195
- GillSSPatelNKHottonGRDirect brain infusion of glial cell line-derived neurotrophic factor in Parkinson diseaseNat Med20039558959512669033
- LoveSPlahaPPatelNKHottonGRBrooksDJGillSSGlial cell line-derived neurotrophic factor induces neuronal sprouting in human brainNat Med200511770370416015352
- KellsAPEberlingJSuXRegeneration of the MPTP-lesioned dopaminergic system after convection-enhanced delivery of AAV2-GDNFJ Neurosci201030289567957720631185
- BaruaNUGillSSLoveSConvection-enhanced drug delivery to the brain: therapeutic potential and neuropathological considerationsBrain Pathol201424211712723944716
- BaruaNULowisSPWoolleyMO’SullivanSHarrisonRGillSSRobot-guided convection-enhanced delivery of carbo-platin for advanced brainstem gliomaActa Neurochir201315581459146523595829
- AndersonRCKennedyBYanesCLConvection-enhanced delivery of topotecan into diffuse intrinsic brainstem tumors in childrenJ Neurosurg Pediatr201311328929523240851
- BruceJNFineRLCanollPRegression of recurrent malignant gliomas with convection-enhanced delivery of topotecanNeurosurgery201169612721279 discussion 1279–128021562434
- FalkenbergKJJohnstoneRWHistone deacetylases and their inhibitors in cancer, neurological diseases and immune disordersNat Rev Drug Discov201413967369125131830
- SturmDBenderSJonesDTPaediatric and adult glioblastoma: multiform (epi)genomic culprits emergeNat Rev Cancer20141429210724457416
- ZhangLChenLHWanHExome sequencing identifies somatic gain-of-function PPM1D mutations in brainstem gliomasNat Genet201446772673024880341
- GrassoCSTangYTruffauxNFunctionally defined therapeutic targets in diffuse intrinsic pontine gliomaNat Med201521655555925939062
- DrappatzJLeeEQHammondSPhase I study of panobinostat in combination with bevacizumab for recurrent high-grade gliomaJ Neurooncol2012107113313821984064
- LeeEQReardonDASchiffDPhase II study of panobinostat in combination with bevacizumab for recurrent glioblastoma and anaplastic gliomaNeuro Oncol201517686286725572329
- RasmussenTATolstrupMMollerHJActivation of latent human immunodeficiency virus by the histone deacetylase inhibitor panobinostat: a pilot study to assess effects on the central nervous systemOpen Forum Infect Dis201521ofv03726034779
- GoldbergJMGlade-BenderJSulisMLA phase I dose finding study of panobinostat in children with hematologic malignancies: initial report of TACL study T2009-012 in children with acute leukemiaBlood20141242137053705
- RodgersLMcCullyCLPeerCCruzRFiggWHG-36 plasma and cerebrospinal fluid (csf) pharmacokinetics of panobinostat following oral administration to nonhuman primatesNeuro Oncol201618suppl 3iii55
- SaitoRKrauzeMTNobleCOTissue affinity of the infusate affects the distribution volume during convection-enhanced delivery into rodent brains: implications for local drug deliveryJ Neurosci Methods20061541–222523216472868
- AhmadZShahASiddiqMKraatzH-BPolymeric micelles as drug delivery vehiclesRSC Adv20144331702817038
- KabanovAVBatrakovaEVMillerDWPluronic block copolymers as modulators of drug efflux transporter activity in the blood-brain barrierAdv Drug Deliv Rev200355115116412535579
- AkashMSRehmanKRecent progress in biomedical applications of Pluronic (PF127): pharmaceutical perspectivesJ Control Release201520912013825921088
- CollinsAMOlofSNMitchelsJMMannSFacile preparation and processing of aqueous dispersions of tris(8-hydroxyquinoline) aluminium(iii) photoluminescent nanoparticlesJ Mater Chem2009192339503954
- CollinsAMZabkiewiczJGhiggiCHauserJCBurnettAKMannSTris(8-hydroxyquinolinato)gallium(III)-loaded copolymer micelles as cytotoxic nanoconstructs for cosolvent-free organometallic drug deliverySmall20117121635164021574252
- WankaGHoffmannHUlbrichtWThe aggregation behavior of poly-(oxyethylene)-poly-(oxypropylene)-poly-(oxyethylene)-block-copoly-mers in aqueous solutionColloid Polym Sci19902682101117
- LuHFLimWSWangJGalactosylated PVDF membrane promotes hepatocyte attachment and functional maintenanceBiomaterials200324274893490314559002
- ZhangWShiYChenYEnhanced antitumor efficacy by paclitaxel-loaded pluronic P123/F127 mixed micelles against non-small cell lung cancer based on passive tumor targeting and modulation of drug resistanceEur J Pharm Biopharm201075334135320451605
- PollardSMYoshikawaKClarkeIDGlioma stem cell lines expanded in adherent culture have tumor-specific phenotypes and are suitable for chemical and genetic screensCell Stem Cell20094656858019497285
- StrickerSHFeberAEngstromPGWidespread resetting of DNA methylation in glioblastoma-initiating cells suppresses malignant cellular behavior in a lineage-dependent mannerGenes Dev201327665466923512659
- ArshadAYangBBienemannASConvection-enhanced delivery of carboplatin PLGA nanoparticles for the treatment of glioblastomaPLoS One2015107e013226626186224
- SiewLKLoveSDawbarnDWilcockGKAllenSJMeasurement of pre- and post-synaptic proteins in cerebral cortex: effects of postmortem delayJ Neurosci Methods2004139215315915488227
- TaylorHBaruaNBienemannAClearance and toxicity of recombinant methionyl human glial cell line-derived neurotrophic factor (r-metHu GDNF) following acute convection-enhanced delivery into the striatumPLoS One201383e5618623526931
- BryantMJChuahTLLuffJLavinMFWalkerDGA novel rat model for glioblastoma multiforme using a bioluminescent F98 cell lineJ Clin Neurosci200815554555118378459
- BarthRFKaurBRat brain tumor models in experimental neuro-oncology: the C6, 9L, T9, RG2, F98, BT4C, RT-2 and CNS-1 gliomasJ Neurooncol200994329931219381449
- OkiYBuglioDZhangJImmune regulatory effects of panobinostat in patients with Hodgkin lymphoma through modulation of serum cytokine levels and T-cell PD1 expressionBlood Cancer J20144e23625105535
- WoodsDMWoanKChengFThe antimelanoma activity of the histone deacetylase inhibitor panobinostat (LBH589) is mediated by direct tumor cytotoxicity and increased tumor immunogenicityMelanoma Res201323534134823963286
- WestACMattarolloSRShorttJAn intact immune system is required for the anticancer activities of histone deacetylase inhibitorsCancer Res201373247265727624158093
- JacksonCRuzevickJPhallenJBelcaidZLimMChallenges in immunotherapy presented by the glioblastoma multiforme microenvironmentClin Dev Immunol2011201173241322190972
- BaruaNUWoolleyMBienemannASIntermittent convection-enhanced delivery to the brain through a novel transcutaneous bone-anchored portJ Neurosci Methods2013214222323223419699
- WhiteEWoolleyMBienemannAA robust MRI-compatible system to facilitate highly accurate stereotactic administration of therapeutic agents to targets within the brain of a large animal modelJ Neurosci Methods20111951788721074564
- BaruaNUHopkinsKWoolleyMA novel implantable catheter system with transcutaneous port for intermittent convection-enhanced delivery of carboplatin for recurrent glioblastomaDrug Deliv201623116717324786643